XML 29 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Oct. 31, 2016
Jan. 31, 2016
Oct. 31, 2015
Jan. 31, 2015
Oct. 31, 2016
Oct. 31, 2015
Oct. 31, 2014
Oct. 31, 2013
Cash flows from operating activities:                
Net loss $ (12,948) $ (11,779) $ (8,905) $ (4,154) $ (51,208) $ (29,684) $ (38,883) $ (38,883)
Adjustments to reconcile net loss to net cash used in operating activities:                
Share-based compensation         3,425 3,157 2,908  
Gain from change in fair value of embedded derivatives         (14) (23) (126)  
Make whole derivative expense         0 0 8,347  
Depreciation         4,949 4,099 4,384  
Amortization of convertible note discount and non-cash interest expense         3,207 1,830 2,140  
Foreign Currency Transaction Gains         (324) (2,075) (571)  
Other non-cash transactions         451 412 146  
Decrease (increase) in operating assets:                
Accounts receivable         30,235 3,173 (15,378)  
Inventories         (8,052) (10,100) 1,059  
Project assets         0 (11,398) 0  
Other assets         (837) 1,022 3,417  
(Decrease) increase in operating liabilities:                
Accounts payable         (3,019) (7,224) (1,566)  
Accrued liabilities         1,240 6,435 (11,056)  
Deferred revenue         (26,648) (3,898) (12,289)  
Net cash used in operating activities         (46,595) (44,274) (57,468)  
Cash flows from investing activities:                
Capital expenditures         (7,726) (6,930) (6,295)  
Expenditures for long-term project assets         (33,726) 0 (784)  
Net cash used in investing activities         (41,452) (6,930) (7,079)  
Cash flows from financing activities:                
Repayment of debt         (30,452) (1,535) (5,971)  
Proceeds from debt         85,935 6,763 250  
Payments of deferred finance costs         (1,758) 0 0  
Purchase of non-controlling shares of subsidiary         (3) 0    
Proceeds from sale of common stock, net of registration fees         70,929 27,060 105,844  
Payment of preferred dividends and return of capital         (4,170) (4,202) (4,343)  
Common stock issued for stock plans and related expenses         177 133 161  
Net cash provided by financing activities         120,658 28,219 95,941  
Effects on cash from changes in foreign currency rates         (35) (108) (260)  
Net increase in cash, cash equivalents, and restricted cash         32,576 (23,093) 31,134  
Cash, cash equivalents, and restricted cash-beginning of year   $ 85,740   $ 108,833 85,740 108,833 77,699  
Cash, cash equivalents, and restricted cash-end of year $ 118,316   $ 85,740   $ 118,316 $ 85,740 $ 108,833 $ 77,699